2Herrington JD, Figueroa JA. Severe necrosis due to paclitaxel extravasation. Pharmacotherapy, 1997,17 : 163 - 165.
3Door RT. Antidotes to vesicant chemotherapy extravasation. Blood Rev, 1990,4:41-60.
4Bertelli G, Gozza A, Formo GB, et al. Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: A prospective clinical study. J Clin Oncol, 1995,13:2851 - 2855.
5Harwood K, Gonin R. Short term vs. long term local cooling after doxorubicin extravasation:An ECOG study. Proc Am Soc Clin Oncol,1994,13:1544.
6Dorr RT, Alberts DS,Stone A. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep, 1985,69:431 - 437.
7Bertelli G, Dini D, FOMO GB, et al. Hyaluronidase as an antidote to extravasation to vinca alkaloids. Cancer Bes Clin Oncol, 1994,120:505 - 506.
8Door RT, Soble M, Alberts DS. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chemother pharmacol, 1988,22:299 - 302.
9Vandeweyer F, Deraemaecker R. Early surgical suction and washout for treatment of cytotoxic drug extravasation, Acta Chlr Belg, 2000,100:37-38.
10Bertelli G. Prevention and management of extravasation of cytotoxic drugs. Drug Saf, 1995,12:245 - 255.
